Procurement Summary
Country : Brazil
Summary : The Acquisition of General Critical Medicines, to Serve the Hospital De Clinicas De Uberlandia - Ebserh Branch (Hc-Ufu/Ebserh), According to Conditions, Quantities, Requirements and Estimates, Established...
Deadline : 06 Feb 2024
Other Information
Notice Type : Tender
TOT Ref.No.: 95769202
Document Ref. No. : 90002/2024
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : Refer Document
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - The acquisition of GENERAL CRITICAL MEDICINES, to serve the Hospital de Clinicas de Uberlandia - EBSERH Branch (HC-UFU/EBSERH), in accordance with the conditions, quantities, requirements and estimates, established in the notice and its annexes.
UASG Code: 156654
Notice from19981d172c851bd4e8a1788d5726c2d3from: 01/24/2024 from 08:00 to 12:00 and from 13:00 to 17:00
Proposal Delivery: from 01/24/2024 to 08:00
PERITONEAL DIALYSIS SOLUTION, COMPOSITION GLUCOSE, SODIUM, CALCIUM, MAGNESIUM, CHLORIDE, LACTATE, CONCENTRATION 1 ABOUT 2.5% 135 MEQ/L 2.5 MEQ/L 1 MEQ/L, CONCENTRATION 2 100 ME19981d172c851bd4e8a1788d5726c2d3Q/L 40 MEQ/L, ADDITIONAL CHARACTERISTICS IN CLOSED SYSTEM
Quantity: 600
PERITONEAL DIALYSIS SOLUTION, COMPOSITION GLUCOSE, SODIUM, CALCIUM, MAGNESIUM, CHLORIDE, LACTATE, CONCENTRATION 1 ABOUT 4.25% 135 MEQ/L 2 .5 MEQ/L 1 MEQ/L, CONCENTRATION 2 100 MEQ/L 40 MEQ/L, ADDITIONAL CHARACTERISTICS19981d172c851bd4e8a1788d5726c2d3NAIS IN CLOSED SYSTEM, WITH APPLICATION SYSTEM
Quantity: 600
ORGAN PRESERVATION SOLUTION, HTK TYPE (HISTIDINE, TRYPTOPHAN AND ALPHA-KETOGLUTARATE), COMPOSITION MANNITOL, SODIUM, POTASSIUM, CALCIUM AND MAGNESIUM, PHARMACEUTICAL FORM SOLUTION FOR INFUSION, STERILE AND APIROGENIC
Quantity: 500
SPOUT19981d172c851bd4e8a1788d5726c2d3SODIUM RBOnate, CONCENTRATION 250 MG, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED
Quantity: 6000
GENTAMYCIN, SULFATE SALT COMPOSITION, CONCENTRATION 5 MG/ML, PHARMACEUTICAL FORM OPHTHALMIC SOLUTION
Quantity: 100
RADIOLOGICAL CONTRAST, PAP OIL-BASED COMPOSITION OULA IODIDA, CONCENTRATIONAT 38% W/W, WITH 480 MG/ML OF IODINE, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 50
RACECADOTRILE, DOSAGE 100 MG
Quantity: 2000
GLUCOSE, CONCENTRATION 40%, PHARMACEUTICAL FORM ORAL GEL, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION ADA
Quantity: 1200
TRICALCIC PHOSPHATE, COMPOSITION19981d172c851bd4e8a1788d5726c2d3CALCIUM PHOSPHORUS, CONCENTRATION 60 32 MG/ML, PHARMACEUTICAL FORM ORAL SUSPENSION, ADDITIONAL CHARACTERISTICS MEDICATION ...
Documents
Tender Notice